Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06527456 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

Study acronym: INDIGO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jul 2026 to Aug 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Dec 2025 to Jan 21, 2026
    v4
  2. Start date: Sep 2025 to Dec 2025
    • Primary and study completion dates: Mar 2027 to Jul 2026
    v3
  3. Primary and study completion dates: Jun 2026 to Mar 2027
    • Start date: Dec 2024 to Sep 2025
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.
Trial Details
NCT Number NCT06527456
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)		 Cervical Cancer
Related terms Uterine Cervical Neoplasms
Enrollment 11,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov